Diabetes Online-Kongress 2021
Kalender
Liste
Personen
Favoriten
zur Liste
Dr. Joachim Kienhöfer
Novo Nordisk Pharma GmbH
Germany
Vortrag
Efficacy of Semaglutide by Background Sodium–Glucose Co-Transporter-2 Inhibitor: a Post Hoc Analysis of SUSTAIN 9
Speaker
Datum: 14.05.2021 , Zeit: 09:26
|
Thema: Posterkurzvortrag
Details
zur online Kongressplattform